TL;DR
This paper introduces MEXA-CTP, a lightweight multi-modal attention model that effectively predicts clinical trial outcomes by integrating diverse data types without relying on prior knowledge or wet lab data, outperforming previous methods.
Contribution
The paper presents a novel mode experts cross-attention model that leverages multi-modal data for clinical trial outcome prediction, avoiding human biases and improving accuracy over existing approaches.
Findings
MEXA-CTP achieves up to 11.3% higher F1 score than previous models.
The model improves PR-AUC by 12.2% on the TOP benchmark.
Ablation studies confirm the effectiveness of each component.
Abstract
Clinical trials are the gold standard for assessing the effectiveness and safety of drugs for treating diseases. Given the vast design space of drug molecules, elevated financial cost, and multi-year timeline of these trials, research on clinical trial outcome prediction has gained immense traction. Accurate predictions must leverage data of diverse modes such as drug molecules, target diseases, and eligibility criteria to infer successes and failures. Previous Deep Learning approaches for this task, such as HINT, often require wet lab data from synthesized molecules and/or rely on prior knowledge to encode interactions as part of the model architecture. To address these limitations, we propose a light-weight attention-based model, MEXA-CTP, to integrate readily-available multi-modal data and generate effective representations via specialized modules dubbed "mode experts", while…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
MethodsHierarchical Information Threading
